Enzo Biochem, Inc.
(ENZB)
Monteverde & Associates Announces the Investigation of Enzo Biochem, Inc.
Sage Therapeutics, Inc.
(SAGE)
Monteverde & Associates Announces the Investigation of Sage Therapeutics, Inc.
Turnstone Biologics Corp.
(TSBX)
Monteverde & Associates Announces the Investigation of Turnstone Biologics Corp.
Guaranty Bancshares, Inc.
(GNTY)
Monteverde & Associates Announces the Investigation of Guaranty Bancshares, Inc.
Carisma Therapeutics Inc.
(CARM)
Monteverde & Associates Announces the Investigation of Carisma Therapeutics Inc.
Verve Therapeutics, Inc.
(VERV)
Monteverde & Associates Announces the Investigation of Verve Therapeutics, Inc.
Cantaloupe, Inc.
(CTLP)
Monteverde & Associates Announces the Investigation of Cantaloupe, Inc.
M2i Global, Inc.
(MTWO)
Monteverde & Associates Announces the Investigation of M2i Global, Inc.
Elevation Oncology, Inc.
(ELEV)
Monteverde & Associates Announces the Investigation of Elevation Oncology, Inc.
Crown Electrokinetics Corp.
(CRKN)
Monteverde & Associates Announces the Investigation of Crown Electrokinetics Corp.
Blueprint Medicines Corporation
(BPMC)
Monteverde & Associates Announces the Investigation of Blueprint Medicines Corporation
Atai Life Sciences N.V.
(ATAI)
Monteverde & Associates Announces the Investigation of Atai Life Sciences N.V.
Heliogen, Inc.
(HLGN)
Monteverde & Associates Announces the Investigation of Heliogen, Inc.
